Arvinas logo

Arvinas Share Price Today

(NASDAQ: ARVN)

Arvinas share price is $17.5 & ₹1,521.96 as on 6 Mar 2025, 2.30 'hrs' IST

$17.5

0.98

(5.9%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Arvinas share price in Dollar and Rupees. Guide to invest in Arvinas stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Arvinas, along with analyst recommendations, forecasts, and comprehensive financials.

Arvinas share price movements

  • Today's Low: $16.41
    Today's High: $17.70

    Day's Volatility :7.32%

  • 52 Weeks Low: $15.53
    52 Weeks High: $49.76

    52 Weeks Volatility :68.79%

Arvinas (ARVN) Returns

PeriodArvinas IncSector (Health Care)Index (Russel 2000)
3 Months
-29.28%
3.7%
0.0%
6 Months
-29.88%
-2.8%
0.0%
1 Year
-61.96%
2.5%
0.0%
3 Years
-71.43%
12.9%
-11.6%

Arvinas (ARVN) Key Statistics

in dollars & INR

Previous Close
$16.52
Open
$16.76
Today's High
$17.7
Today's Low
$16.405
Market Capitalization
$1.1B
Today's Volume
$1.2M
52 Week High
$49.76
52 Week Low
$15.53
Revenue TTM
$263.4M
EBITDA
$-245.6M
Earnings Per Share (EPS)
$-2.82
Profit Margin
-75.51%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-32.56%

How to invest in Arvinas Stock (ARVN) from India?

It is very easy for Indian residents to invest directly in Arvinas from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Arvinas stock in both Indian Rupees (INR) and US Dollars (USD). Search for Arvinas or ARVN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Arvinas or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Arvinas shares which would translate to 0.050 fractional shares of Arvinas as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Arvinas, in just a few clicks!

Returns in Arvinas (ARVN) for Indian investors in Rupees

The Arvinas stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Arvinas investment value today

Current value as on today

₹43,001

Returns

₹56,999

(-57%)

Returns from Arvinas Stock

₹61,948 (-61.95%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Arvinas (ARVN)

-57%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Arvinas Stock from India on INDmoney has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Arvinas

  • Vanguard Group Inc

    10.27%

  • EcoR1 Capital, LLC

    9.78%

  • BlackRock Inc

    9.55%

  • T. Rowe Price Associates, Inc.

    5.97%

  • RTW INVESTMENTS, LLC

    4.85%

  • Citadel Advisors Llc

    4.47%

Analyst Recommendation on Arvinas

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 26 Wall street analysts offering stock ratings for Arvinas(by analysts ranked 0 to 5 stars)

Based on 26 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
23
23
24
Hold
3
3
2
Sell
0
0
0

Analyst Forecast on Arvinas Stock (ARVN)

What analysts predicted

Upside of 246.86%

Target:

$60.70

Current:

$17.50

Insights on Arvinas Stock (Ticker Symbol: ARVN)

  • Price Movement

    In the last 3 months, ARVN stock has moved down by -32.5%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 102.4M → 59.2M (in $), with an average decrease of 42.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -49.2M → -45.1M (in $), with an average increase of 9.1% per quarter
  • ARVN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 128.5%
  • ARVN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 124.5%
  • Price to Sales

    ForARVN every $1 of sales, investors are willing to pay $4.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Arvinas Technicals Summary

Sell

Neutral

Buy

Arvinas is currently in a neutral trading position according to technical analysis indicators.

Arvinas (ARVN) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Arvinas Inc logo
-3.07%
-29.88%
-61.96%
-71.43%
-62.45%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Arvinas Inc logo
NA
NA
NA
-3.95
-0.33
-0.13
NA
8.16
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Arvinas Inc logo
Buy
$1.1B
-62.45%
NA
-75.51%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Arvinas

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 3 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. The company's products also consists ARV 393, orally bioavailable PROTAC designed to degrade BCL6, a transcriptional repressor and a key regulator of normal B-cell maturation and differentiation processes which is in Phase 1 first-in-human clinical trial; ARV 102 for the treatment of neurodegenerative diseases, which is in Phase 1 clinical trial; and KRAS G12D program is in preclinical development for pancreatic and colorectal cancers. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.
Organization
Arvinas
Employees
430
CEO
Dr. John G. Houston Ph.D.
Industry
Health Technology

Management People of Arvinas

NameTitle
Dr. John G. Houston Ph.D.
Chairperson, CEO & President
Dr. Ian Taylor Ph.D.
President of Research & Development and Chairman of Scientific Advisory Board
Mr. Andrew R. Saik
CFO & Treasurer
Mr. David K. Loomis M.B.A.
VP & Chief Accounting Officer
Ms. Angela M. Cacace Ph.D.
Chief Scientific Officer
Mr. Jared M. Freedberg J.D.
General Counsel & Corporate Secretary
Mr. Steve Weiss
Senior VP & Chief Human Resources Officer
Dr. Randy Teel Ph.D.
Chief Business Officer
Ms. Lisa Sinclair
Senior Vice President of Corporate Operations
Mr. Paul McInulty
Senior Vice President of Regulatory Affairs

Important FAQs about investing in ARVN Stock from India :

What is Arvinas share price today?

Arvinas share price today stands at $17.50, Open: $16.76 ; Previous Close: $16.52 ; High: $17.70 ; Low: $16.41 ; 52 Week High: $49.76 ; 52 Week Low: $15.53.

The stock opens at $16.76, after a previous close of $16.52. The stock reached a daily high of $17.70 and a low of $16.41, with a 52-week high of $49.76 and a 52-week low of $15.53.

Can Indians buy Arvinas shares?

Yes, Indians can invest in the Arvinas (ARVN) from India.

With INDmoney, you can buy Arvinas at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Arvinas at zero transaction cost.

How can I buy Arvinas shares from India?

It is very easy to buy Arvinas from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Arvinas (ARVN) be purchased?

Yes, you can buy fractional shares of Arvinas with INDmoney app.

What are the documents required to start investing in Arvinas stocks?

To start investing in Arvinas, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Arvinas Stock (ARVN)?

Today’s highest price of Arvinas (ARVN) is $17.70.

Today’s lowest price of Arvinas (ARVN) is $16.41.

What is today's market capitalisation of Arvinas?

Today's market capitalisation of Arvinas ARVN is 1.1B

What is the 52 Week High and Low Range of Arvinas Stock (ARVN)?

  • 52 Week High

    $49.76

  • 52 Week Low

    $15.53

What are the historical returns of Arvinas (ARVN)?

  • 1 Month Returns

    -3.07%

  • 3 Months Returns

    -29.88%

  • 1 Year Returns

    -61.96%

  • 5 Years Returns

    -62.45%

Who is the Chief Executive Officer (CEO) of Arvinas ?

Dr. John G. Houston Ph.D. is the current Chief Executive Officer (CEO) of Arvinas.